New User Fee Agreements Aim at Ensuring Relief From High Drug Prices: But Trump's Budget Proposal Threatens to Upend Completed Negotiations.
نویسنده
چکیده
The next iterations of the Generic Drug User Fee Act and the Biosimilar User Fee Act are meant to encourage new generic and biosimilar products, but higher fees and budget reductions may threaten progress.
منابع مشابه
Lessons from the Physician Group Practice Demonstration--a sobering reflection.
1659 indeed, the evidence to date suggests that when drug coverage for dual eligibles switched from Medi caid to Medicare, the prices for their drugs increased significantly.5 It’s on the basis of such logic that Obama’s recent proposal can be justified. A policy requiring that drug manufacturers offer subsidized Medicare beneficiaries the same prices that Medicaid pays represents an interventi...
متن کاملCriteria for Drug Pricing: Preliminary Experiences with Modeling the Price-Volume Relationship
In managing drug prices at the national level, price-volume agreements are a tool aimed at ensuring sustainability in cases where the drug price is high and the population is large. These agreements in fact determine a progressive price reduction as more and more patients are treated. Price decays in this context generally have a purely empirical nature, but a theoretical basis would be needed....
متن کاملTRIPs-Plus Treaties and Strengthening Protection of Pharmaceutical Inventions
After concluding TRIPs agreement, the sphere of negotiation in respect of protecting new kinds of intellectual property rights especially pharmaceutical inventions transferred to bilateral and regional arrangements. TRIPs agreement has some flexibility to attract all countries. Industrialized countries believed that multilateral agreements protections based especially in regard of pharmaceutica...
متن کاملAnnuity payments can increase patient access to innovative cell and gene therapies under England’s net budget impact test
Background: Cell and gene therapies have the potential to provide therapeutic breakthroughs, but the high costs of researching, developing, manufacturing and delivering them translate into prices that may challenge healthcare budgets. Various measures exist that aim to address the affordability challenge, including reducing price, limiting patient numbers and/or linking remuneration to product ...
متن کاملHow Have User Fees Affected the FDA?
Some policy experts answer that question by arguing that budget constraints contributed to regulatory delays in the past. The reform simply relaxed those constraints by increasing the resources for new-drug review. However, there is little empirical evidence to suggest that changes in the fda’s budget influenced regulatory delays and the speed of review prior to user fees. Other policy experts ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- P & T : a peer-reviewed journal for formulary management
دوره 42 5 شماره
صفحات -
تاریخ انتشار 2017